India's pharmaceutical exports are projected to double from approximately $27 billion in 2023 to reach $65 billion by 2030, a ...

Currently valued at around USD 55 billion, the Indian pharma market is expected to more than double over the next six years, reaching an estimated USD 120 billion to USD 130 billion. By 2047, the ...

The global pharmaceutical industry is valued at approximately $1.6 trillion, while India's market stands at $55 billion, ...

Bain & Company in collaboration with Indianpharmaceutical bodies said exports of India’s pharmaceutical industry are ...

India's pharmaceutical sector is witnessing remarkable growth, almost achieving its export target before FY25. Drug formulations and biologicals lead the exports, supported by significant growth in ...

India's pharmaceutical ... particularly in Active Pharmaceutical Ingredients (APIs), biosimilars, and generic formulations. The Bain & Company report highlights key areas for growth, including API ...

Indian oil companies are looking to buy U.S. liquefied natural gas (LNG), buoyed by the Trump administration's lifting of a ...

There is a risk of collateral damage to Indian exports as Trump injects significant uncertainty into global markets ...

In FY24 (Till February 2024), premiums underwritten by health insurance companies grew ... billion in technical textile exports by 2025-26 under the US$ 169.2 million National Technical Textiles ...